
Opinion|Videos|August 21, 2024
Managing Adverse Events in Novel Friedreich’s Ataxia Therapy
A key opinion leader outlines common adverse events associated with omaveloxolone treatment in Friedreich's ataxia patients and describes strategies used to manage or minimize these adverse effects.
Advertisement
Episodes in this series

- What adverse events are typically encountered with omaveloxolone, what strategies do you employ to mitigate or address them effectively and under what circumstances should omaveloxolone be discontinued, if at all?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
2
Top 5 Myasthenia Gravis Content of 2025
3
Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes
4
House Republicans Block Vote on ACA Subsidy Extension
5









































